Ngā hua rapu - Cixin He
- E whakaatu ana i te 1 - 8 hua o te 8
-
1
Molecular Dissection of Developmental Behavior of Plant Height in Rice (Oryza sativa L.) mā Juqiang Yan, Jun Zhu, Cixin He, Mebrouk Benmoussa, Ping Wu
I whakaputaina 1998Artigo -
2
-
3
Lenvatinib Plus Everolimus or Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Study Design and Rationale mā Viktor Grünwald, Thomas Powles, Toni K. Choueiri, Thomas E. Hutson, Camillo Porta, Masatoshi Eto, Cora N. Sternberg, Sun Young Rha, Cixin He, Corina E. Dutcus, Alan D. Smith, Lea Dutta, Kalgi Mody, Robert J. Motzer
I whakaputaina 2019Artigo -
4
Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomis... mā Robert J. Motzer, Camillo Porta, B. Yа. Alekseev, Sun Young Rha, Toni K. Choueiri, María José Méndez-Vidal, Sung‐Hoo Hong, Anil Kapoor, Jeffrey C. Goh, Masatoshi Eto, Lee Bennett, Jinyi Wang, Jie Janice Pan, Todd L. Saretsky, Rodolfo F. Perini, Cixin He, Kalgi Mody, David Cella
I whakaputaina 2022Artigo -
5
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study mā Nathalie Gaspar, Rajkumar Venkatramani, Stefanie Hecker‐Nolting, Soledad Gallego, Franco Locatelli, Francisco Bautista, Alessandra Longhi, Cyril Lervat, Natacha Entz‐Werlé, Michela Casanova, Isabelle Aerts, Sandra J. Strauss, Estelle Thébaud, Bruce Morland, Adela Cañete, Perrine Marec‐Bérard, Marion Gambart, Claudia Rössig, Chinyere E. Okpara, Cixin He, Lea Dutta, Quentin Campbell‐Hewson
I whakaputaina 2021Artigo -
6
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆ mā Nathalie Gaspar, Quentin Campbell‐Hewson, Soledad Gallego, Franco Locatelli, Rajkumar Venkatramani, Stefanie Hecker‐Nolting, Marion Gambart, Francisco Bautista, Estelle Thébaud, Isabelle Aerts, Bruce Morland, Claudia Rössig, Adela Cañete, Alessandra Longhi, Cyril Lervat, N. Entz-Werle, Sandra J. Strauss, Perrine Marec‐Bérard, Chinyere E. Okpara, Cixin He, Lea Dutta, Michela Casanova
I whakaputaina 2021Artigo -
7
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms mā Viktor Grünwald, Thomas Powles, Masatoshi Eto, Evgeny Kopyltsov, Sun Young Rha, Camillo Porta, Robert J. Motzer, Thomas E. Hutson, María José Méndez-Vidal, Sung‐Hoo Hong, Eric Winquist, Jeffrey C. Goh, Pablo Maroto, Tomáš Büchler, Toshio Takagi, Joseph E. Burgents, Rodolfo F. Perini, Cixin He, Chinyere E. Okpara, Jodi A. McKenzie, Toni K. Choueiri
I whakaputaina 2023Artigo -
8
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study mā Robert J. Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E. Hutson, B. Yа. Alekseev, Sun Young Rha, Jaime R. Merchan, Jeffrey C. Goh, Aly‐Khan A. Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung‐Hoo Hong, Howard Gurney, María José Méndez-Vidal, Evgeny Kopyltsov, Sergei Tjulandin, Teresa Alonso‐Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph E. Burgents, Cixin He, Chinyere E. Okpara, Jodi A. McKenzie, Toni K. Choueiri, Robert J. Motzer, Toni K. Choueiri, Thomas E. Hutson, Luke T. Nordquist, David R. Spigel, Jaime R. Merchan, Saby George, Sandhya Srinivas, Brendan D. Curti, Andrew Pippas, Elisabeth I. Heath, Subramanya Rao, Theodore Stewart Gourdin, Mehmood Hashmi, Nafisa Burhani, Ana M. Molina, Alan J. Koletsky, Robert Alter, C. Alemany, Benjamin A. Gartrell, Mike Cusnir, Harsha Vyas, Stephanie L. Graff, Christian Squillante, Mark Knapp, Ivor Percent, Vijay Patel, Daniel L. Spitz, C. Harkness, Marc Matrana, Lindsay Overton, Stephen Richey, Donald Richards, Habib M. Ghaddar, Robert Galamaga, Ralph J. Hauke, Joseph Haggerty, Ronald Harris, Mark Johns, Samith T. Kochuparambil, Christian Kollmannsberger, Bobby Shayegan, Christina Canil, Eric Winquist, Catherine Sperlich, Georg A. Bjarnason, Naveen S. Basappa, Wolfgang Loidl, Wolfgang Horninger, Manuela Schmidinger, Lionel D’Hondt, Dirk Schrijvers, Annemie Rutten, Peter Schatteman, Wim Wynendaele, Daisy Luyten, Spyridon Sideris, Christine Gennigens, Bohuslav Melichar, Jana Katolická, Jiří Tomášek, Jana Prausová, Tomáš Büchler, Petra Holečková
I whakaputaina 2024Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cancer
Internal medicine
Lenvatinib
Medicine
Oncology
Clinical endpoint
Clinical trial
Immunotherapy
Pembrolizumab
Renal cell carcinoma
Sunitinib
Everolimus
Hepatocellular carcinoma
Kidney cancer
Sorafenib
Thyroid cancer
Adverse effect
Astrobiology
Biology
Confidence interval
Demography
Doubled haploidy
Gene
Genetics
Oryza sativa
Phases of clinical research
Physics
Population
Quantitative trait locus
Refractory (planetary science)